{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:04:58Z","timestamp":1793736298650,"version":"4.6.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Fontan operation creates a unique circulation, and is a palliative therapy for patients with single-ventricle congenital heart disease. Increased venous pressure and decreased cardiac output and hepatic venous drainage result in sinusoidal dilatation around the central veins. This causes congestion and hypoxia in the liver, leading to Fontan-associated liver disease (FALD). Non-invasive and invasive markers enable diagnosis and evaluation of the fibrosis status in chronic liver disease; however, these markers have not been validated in FALD. Additionally, regenerative nodules such as focal nodular hyperplasia (FNH) are frequently found. The severity of fibrosis correlates with the duration of the Fontan procedure and the central venous pressure. Cirrhosis is a risk factor for hepatocellular carcinoma (HCC), the annual risk of which is 1.5\u20135.0%. HCC is frequently difficult to diagnose and treat because of cardiac complications, coagulopathy, and congenital abnormalities. The mortality rate of FALD with liver cirrhosis and\/or FALD-HCC was increased to\u2009~\u200929.4% (5\/17 cases) in a nationwide survey. Although there is no consensus on the surveillance of patients with FALD, serial monitoring of the alpha fetoprotein level and imaging at 6-month intervals is required in patients with cirrhosis.<\/jats:p>","DOI":"10.1038\/s41598-020-78840-y","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T11:09:12Z","timestamp":1607598552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Fontan-associated liver disease and hepatocellular carcinoma in adults"],"prefix":"10.1038","volume":"10","author":[{"given":"Tomomi","family":"Kogiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"78840_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/thx.26.3.240","volume":"26","author":"F Fontan","year":"1971","unstructured":"Fontan, F. & Baudet, E. Surgical repair of tricuspid atresia. Thorax 26, 240\u2013248 (1971).","journal-title":"Thorax"},{"key":"78840_CR2","doi-asserted-by":"publisher","first-page":"I157","DOI":"10.1161\/CIRCULATIONAHA.106.676445","volume":"116","author":"Y d'Udekem","year":"2007","unstructured":"d\u2019Udekem, Y. et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116, I157-164. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.676445 (2007).","journal-title":"Circulation"},{"key":"78840_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.107.738559","volume":"117","author":"P Khairy","year":"2008","unstructured":"Khairy, P. et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117, 85\u201392. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.738559 (2008).","journal-title":"Circulation"},{"key":"78840_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2014.10.032","volume":"115","author":"I Lindsay","year":"2015","unstructured":"Lindsay, I., Johnson, J., Everitt, M. D., Hoffman, J. & Yetman, A. T. Impact of liver disease after the fontan operation. Am. J. Cardiol. 115, 249\u2013252. https:\/\/doi.org\/10.1016\/j.amjcard.2014.10.032 (2015).","journal-title":"Am. J. Cardiol."},{"key":"78840_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jtcvs.2004.10.005","volume":"129","author":"AA Ghaferi","year":"2005","unstructured":"Ghaferi, A. A. & Hutchins, G. M. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J. Thorac. Cardiovasc. Surg. 129, 1348\u20131352. https:\/\/doi.org\/10.1016\/j.jtcvs.2004.10.005 (2005).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"78840_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1056\/NEJMc1214222","volume":"368","author":"SK Asrani","year":"2013","unstructured":"Asrani, S. K., Warnes, C. A. & Kamath, P. S. Hepatocellular carcinoma after the Fontan procedure. N. Engl. J. Med. 368, 1756\u20131757. https:\/\/doi.org\/10.1056\/NEJMc1214222 (2013).","journal-title":"N. Engl. J. Med."},{"key":"78840_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11748-019-01068-9","volume":"67","author":"H Shimizu","year":"2019","unstructured":"Shimizu, H. et al. Thoracic and cardiovascular surgery in Japan in 2016: annual report by The Japanese Association for Thoracic Surgery. Gen. Thorac. Cardiovasc. Surg. 67, 377\u2013411. https:\/\/doi.org\/10.1007\/s11748-019-01068-9 (2019).","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"78840_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nrcardio.2010.99","volume":"7","author":"MR de Leval","year":"2010","unstructured":"de Leval, M. R. & Deanfield, J. E. Four decades of Fontan palliation. Nat. Rev. Cardiol. 7, 520\u2013527. https:\/\/doi.org\/10.1038\/nrcardio.2010.99 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"78840_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jtcvs.2019.11.048","volume":"159","author":"VHM Weixler","year":"2020","unstructured":"Weixler, V. H. M. et al. Fontan with lateral tunnel is associated with improved survival compared with extracardiac conduit. J. Thorac. Cardiovasc. Surg. 159, 1480-1491.e1482. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.11.048 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"78840_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/NCI.0b013e31829744c7","volume":"24","author":"ME McRae","year":"2013","unstructured":"McRae, M. E. Long-term issues after the Fontan procedure. AACN Adv. Crit. Care 24, 264\u2013282. https:\/\/doi.org\/10.1097\/NCI.0b013e31829744c7 (2013) ((quiz 283\u2013264)).","journal-title":"AACN Adv. Crit. Care"},{"key":"78840_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/hep.25692","volume":"56","author":"SK Asrani","year":"2012","unstructured":"Asrani, S. K. et al. Congenital heart disease and the liver. Hepatology 56, 1160\u20131169. https:\/\/doi.org\/10.1002\/hep.25692 (2012).","journal-title":"Hepatology"},{"key":"78840_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/heartjnl-2011-301133","volume":"98","author":"BJ Deal","year":"2012","unstructured":"Deal, B. J. & Jacobs, M. L. Management of the failing Fontan circulation. Heart 98, 1098\u20131104. https:\/\/doi.org\/10.1136\/heartjnl-2011-301133 (2012).","journal-title":"Heart"},{"key":"78840_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/hrt.2006.094516","volume":"93","author":"CH Kiesewetter","year":"2007","unstructured":"Kiesewetter, C. H. et al. Hepatic changes in the failing Fontan circulation. Heart 93, 579\u2013584. https:\/\/doi.org\/10.1136\/hrt.2006.094516 (2007).","journal-title":"Heart"},{"key":"78840_CR14","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1016\/j.jacc.2017.10.045","volume":"70","author":"CJ Daniels","year":"2017","unstructured":"Daniels, C. J. et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015 Washington DC. J. Am. Coll. Cardiol. 70, 3173\u20133194. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.045 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"78840_CR15","doi-asserted-by":"publisher","first-page":"G549","DOI":"10.1152\/ajpgi.1985.249.5.G549","volume":"249","author":"WW Lautt","year":"1985","unstructured":"Lautt, W. W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am. J. Physiol. 249, G549-556. https:\/\/doi.org\/10.1152\/ajpgi.1985.249.5.G549 (1985).","journal-title":"Am. J. Physiol."},{"key":"78840_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jjcc.2016.04.001","volume":"68","author":"H Ohuchi","year":"2016","unstructured":"Ohuchi, H. Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation?. J. Cardiol. 68, 181\u2013189. https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.001 (2016).","journal-title":"J. Cardiol."},{"key":"78840_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5604\/01.3001.0010.8634","volume":"17","author":"L T\u00e9llez","year":"2018","unstructured":"T\u00e9llez, L., Rodr\u00edguez-Santiago, E. & Albillos, A. Fontan-associated liver disease: a review. Ann Hepatol 17, 192\u2013204. https:\/\/doi.org\/10.5604\/01.3001.0010.8634 (2018).","journal-title":"Ann Hepatol"},{"key":"78840_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1747-0803.2011.00504.x","volume":"6","author":"FM Wu","year":"2011","unstructured":"Wu, F. M. et al. Liver disease in the patient with Fontan circulation. Congenit. Heart Dis. 6, 190\u2013201. https:\/\/doi.org\/10.1111\/j.1747-0803.2011.00504.x (2011).","journal-title":"Congenit. Heart Dis."},{"key":"78840_CR19","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1136\/hrt.2010.201772","volume":"96","author":"JS Baek","year":"2010","unstructured":"Baek, J. S. et al. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96, 1750\u20131755. https:\/\/doi.org\/10.1136\/hrt.2010.201772 (2010).","journal-title":"Heart"},{"key":"78840_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.healun.2016.07.011","volume":"36","author":"FM Wu","year":"2017","unstructured":"Wu, F. M. et al. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J. Heart Lung Transplant. 36, 211\u2013219. https:\/\/doi.org\/10.1016\/j.healun.2016.07.011 (2017).","journal-title":"J. Heart Lung Transplant."},{"key":"78840_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.athoracsur.2008.03.077","volume":"86","author":"S Camposilvan","year":"2008","unstructured":"Camposilvan, S. et al. Liver and cardiac function in the long term after Fontan operation. Ann. Thorac. Surg. 86, 177\u2013182. https:\/\/doi.org\/10.1016\/j.athoracsur.2008.03.077 (2008).","journal-title":"Ann. Thorac. Surg."},{"key":"78840_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.9794\/jspccs.29.162","volume":"29","author":"T Fujisawa","year":"2013","unstructured":"Fujisawa, T. & Tanaka, Y. Liver diseases in the fontan circulation. Pediatr. Cardiol Cardiac Surg. 29, 162\u2013170 (2013).","journal-title":"Pediatr. Cardiol Cardiac Surg."},{"key":"78840_CR23","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s00380-015-0743-4","volume":"31","author":"M Shimizu","year":"2016","unstructured":"Shimizu, M. et al. Risk factors and serological markers of liver cirrhosis after Fontan procedure. Heart Vessels 31, 1514\u20131521. https:\/\/doi.org\/10.1007\/s00380-015-0743-4 (2016).","journal-title":"Heart Vessels"},{"key":"78840_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno, A. et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci. Rep. 3, 1065. https:\/\/doi.org\/10.1038\/srep01065 (2013).","journal-title":"Sci. Rep."},{"key":"78840_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s13244-018-0609-2","volume":"9","author":"TH Kim","year":"2018","unstructured":"Kim, T. H. et al. Abdominal imaging findings in adult patients with Fontan circulation. Insights Imaging 9, 357\u2013367. https:\/\/doi.org\/10.1007\/s13244-018-0609-2 (2018).","journal-title":"Insights Imaging"},{"key":"78840_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/hepr.13248","volume":"49","author":"T Nakatsuka","year":"2019","unstructured":"Nakatsuka, T. et al. Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation. Hepatol. Res. 49, 304\u2013313. https:\/\/doi.org\/10.1111\/hepr.13248 (2019).","journal-title":"Hepatol. Res."},{"key":"78840_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ijcard.2015.09.088","volume":"202","author":"D Wolff","year":"2016","unstructured":"Wolff, D. et al. The Fontan circulation and the liver: a magnetic resonance diffusion-weighted imaging study. Int. J. Cardiol. 202, 595\u2013600. https:\/\/doi.org\/10.1016\/j.ijcard.2015.09.088 (2016).","journal-title":"Int. J. Cardiol."},{"key":"78840_CR28","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1038\/s41598-020-61618-7","volume":"10","author":"K Nakajima","year":"2020","unstructured":"Nakajima, K. et al. Visual liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging of patients in the early post-Fontan period. Sci. Rep. 10, 4909. https:\/\/doi.org\/10.1038\/s41598-020-61618-7 (2020).","journal-title":"Sci. Rep."},{"key":"78840_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/chd.12159","volume":"9","author":"FM Wu","year":"2014","unstructured":"Wu, F. M. et al. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit. Heart Dis. 9, 438\u2013447. https:\/\/doi.org\/10.1111\/chd.12159 (2014).","journal-title":"Congenit. Heart Dis."},{"key":"78840_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jjcc.2016.05.016","volume":"68","author":"M Sugimoto","year":"2016","unstructured":"Sugimoto, M. et al. Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair. J. Cardiol. 68, 202\u2013208. https:\/\/doi.org\/10.1016\/j.jjcc.2016.05.016 (2016).","journal-title":"J. Cardiol."},{"key":"78840_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2214\/AJR.18.19762","volume":"211","author":"N Horvat","year":"2018","unstructured":"Horvat, N. et al. Multimodality screening of hepatic nodules in patients with congenital heart disease after Fontan procedure: role of ultrasound, ARFI elastography, CT, and MRI. AJR 211, 1212\u20131220. https:\/\/doi.org\/10.2214\/AJR.18.19762 (2018).","journal-title":"AJR"},{"key":"78840_CR32","doi-asserted-by":"publisher","first-page":"e012529","DOI":"10.1161\/JAHA.119.012529","volume":"9","author":"SL Rathgeber","year":"2020","unstructured":"Rathgeber, S. L. et al. Fontan-associated liver disease: spectrum of disease in children and adolescents. J. Am. Heart Assoc. 9, e012529. https:\/\/doi.org\/10.1161\/JAHA.119.012529 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"78840_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/2150135114530172","volume":"5","author":"JL Melero-Ferrer","year":"2014","unstructured":"Melero-Ferrer, J. L. et al. Fontan circulation in adult patients: acoustic radiation force impulse elastography as a useful tool for liver assessment. World J. Pediatr. Congenit. Heart Surg. 5, 365\u2013371. https:\/\/doi.org\/10.1177\/2150135114530172 (2014).","journal-title":"World J. Pediatr. Congenit. Heart Surg."},{"key":"78840_CR34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jhep.2018.05.037","volume":"69","author":"CR Bradley","year":"2018","unstructured":"Bradley, C. R. et al. Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging. J. Hepatol. 69, 1015\u20131024. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.037 (2018).","journal-title":"J. Hepatol."},{"key":"78840_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jtcvs.2012.09.005","volume":"146","author":"JA Johnson","year":"2013","unstructured":"Johnson, J. A. et al. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J. Thorac. Cardiovasc. Surg. 146, 140\u2013145. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.005 (2013).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"78840_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/jcp.2007.052365","volume":"61","author":"TJ Kendall","year":"2008","unstructured":"Kendall, T. J. et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J. Clin. Pathol. 61, 504\u2013508. https:\/\/doi.org\/10.1136\/jcp.2007.052365 (2008).","journal-title":"J. Clin. Pathol."},{"key":"78840_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00246-012-0402-9","volume":"34","author":"MC Schwartz","year":"2013","unstructured":"Schwartz, M. C. et al. Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr. Cardiol. 34, 135\u2013142. https:\/\/doi.org\/10.1007\/s00246-012-0402-9 (2013).","journal-title":"Pediatr. Cardiol."},{"key":"78840_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1621746","author":"H Komatsu","year":"2019","unstructured":"Komatsu, H. et al. Liver disease secondary to congenital heart disease in children. Expert Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1080\/17474124.2019.1621746 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"78840_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cld.573","volume":"8","author":"M Hilscher","year":"2016","unstructured":"Hilscher, M. & Sanchez, W. Congestive hepatopathy. Clin. Liver Dis. (Hoboken) 8, 68\u201371. https:\/\/doi.org\/10.1002\/cld.573 (2016).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"78840_CR40","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc, M. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864\u2013871. https:\/\/doi.org\/10.1053\/he.2000.5852 (2000).","journal-title":"Hepatology"},{"key":"78840_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/lt.20906","volume":"13","author":"DM Heuman","year":"2007","unstructured":"Heuman, D. M. et al. MELD-XI: a rational approach to \u201csickest first\u201d liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 13, 30\u201337. https:\/\/doi.org\/10.1002\/lt.20906 (2007).","journal-title":"Liver Transpl."},{"key":"78840_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00246-016-1428-1","volume":"37","author":"WN Evans","year":"2016","unstructured":"Evans, W. N. et al. MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores. Pediatr. Cardiol. 37, 1274\u20131277. https:\/\/doi.org\/10.1007\/s00246-016-1428-1 (2016).","journal-title":"Pediatr. Cardiol."},{"key":"78840_CR43","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.amjcard.2017.02.005","volume":"119","author":"CJ Berg","year":"2017","unstructured":"Berg, C. J., Bauer, B. S., Hageman, A., Aboulhosn, J. A. & Reardon, L. C. Mortality risk stratification in Fontan patients who underwent heart transplantation. Am. J. Cardiol. 119, 1675\u20131679. https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.005 (2017).","journal-title":"Am. J. Cardiol."},{"key":"78840_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.02.016","author":"TT Gordon-Walker","year":"2019","unstructured":"Gordon-Walker, T. T., Bove, K. & Veldtman, G. Fontan-associated liver disease: a review. J. Cardiol. https:\/\/doi.org\/10.1016\/j.jjcc.2019.02.016 (2019).","journal-title":"J. Cardiol."},{"key":"78840_CR45","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/jhep.2002.36128","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns, X. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36, 986\u2013992. https:\/\/doi.org\/10.1053\/jhep.2002.36128 (2002).","journal-title":"Hepatology"},{"key":"78840_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson, S. et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am. J. Gastroenterol. 112, 740\u2013751. https:\/\/doi.org\/10.1038\/ajg.2016.453 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"78840_CR47","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1016\/j.ijcard.2013.06.008","volume":"168","author":"RW Elder","year":"2013","unstructured":"Elder, R. W. et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int. J. Cardiol. 168, 3764\u20133769. https:\/\/doi.org\/10.1016\/j.ijcard.2013.06.008 (2013).","journal-title":"Int. J. Cardiol."},{"key":"78840_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.hlc.2019.09.010","volume":"29","author":"D Zentner","year":"2020","unstructured":"Zentner, D. et al. Management of people with a Fontan circulation: a cardiac society of Australia and New Zealand Position statement. Heart Lung Circ. 29, 5\u201339. https:\/\/doi.org\/10.1016\/j.hlc.2019.09.010 (2020).","journal-title":"Heart Lung Circ."},{"key":"78840_CR49","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1253\/circj.CJ-17-1053","volume":"82","author":"M Kuwabara","year":"2018","unstructured":"Kuwabara, M. et al. Liver cirrhosis and\/or hepatocellular carcinoma occurring late after the fontan procedure\u2014a nationwide survey in Japan. Circ. J. 82, 1155\u20131160. https:\/\/doi.org\/10.1253\/circj.CJ-17-1053 (2018).","journal-title":"Circ. J."},{"key":"78840_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","volume":"51","author":"H Fukui","year":"2016","unstructured":"Fukui, H. et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J. Gastroenterol. 51, 629\u2013650. https:\/\/doi.org\/10.1007\/s00535-016-1216-y (2016).","journal-title":"J. Gastroenterol."},{"key":"78840_CR51","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.amjcard.2015.11.014","volume":"117","author":"K Pundi","year":"2016","unstructured":"Pundi, K. et al. Liver disease in patients after the Fontan operation. Am. J. Cardiol. 117, 456\u2013460. https:\/\/doi.org\/10.1016\/j.amjcard.2015.11.014 (2016).","journal-title":"Am. J. Cardiol."},{"key":"78840_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.21037\/acs.2018.01.01","volume":"7","author":"R Bryant","year":"2018","unstructured":"Bryant, R. & Morales, D. Overview of adult congenital heart transplants. Ann. Cardiothorac. Surg. 7, 143\u2013151. https:\/\/doi.org\/10.21037\/acs.2018.01.01 (2018).","journal-title":"Ann. Cardiothorac. Surg."},{"key":"78840_CR53","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jhep.2019.10.027","volume":"72","author":"L T\u00e9llez","year":"2020","unstructured":"T\u00e9llez, L. et al. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort. J. Hepatol. 72, 702\u2013710. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.027 (2020).","journal-title":"J. Hepatol."},{"key":"78840_CR54","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.117.032717","volume":"138","author":"AC Egbe","year":"2018","unstructured":"Egbe, A. C. et al. Hepatocellular carcinoma after Fontan operation. Circulation 138, 746\u2013748. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032717 (2018).","journal-title":"Circulation"},{"key":"78840_CR55","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s10620-013-2832-5","volume":"59","author":"KB Johnson","year":"2014","unstructured":"Johnson, K. B. et al. Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig. Dis. Sci. 59, 174\u2013182. https:\/\/doi.org\/10.1007\/s10620-013-2832-5 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"78840_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13500","author":"T Sagawa","year":"2020","unstructured":"Sagawa, T. et al. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease. Hepatol. Res. https:\/\/doi.org\/10.1111\/hepr.13500 (2020).","journal-title":"Hepatol. Res."},{"key":"78840_CR57","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1440-1746.2011.06659.x","volume":"26","author":"JY Choi","year":"2011","unstructured":"Choi, J. Y. et al. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J. Gastroenterol. Hepatol. 26, 1004\u20131009. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06659.x (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"78840_CR58","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/s0168-8278(00)80248-2","volume":"32","author":"MA Khan","year":"2000","unstructured":"Khan, M. A. et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J. Hepatol. 32, 792\u2013797. https:\/\/doi.org\/10.1016\/s0168-8278(00)80248-2 (2000).","journal-title":"J. Hepatol."},{"key":"78840_CR59","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00261-017-1181-9","volume":"42","author":"ML Wells","year":"2017","unstructured":"Wells, M. L. et al. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom. Radiol. (NY) 42, 2623\u20132631. https:\/\/doi.org\/10.1007\/s00261-017-1181-9 (2017).","journal-title":"Abdom. Radiol. (NY)"},{"key":"78840_CR60","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000343875","volume":"3","author":"M Kudo","year":"2014","unstructured":"Kudo, M. et al. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer 3, 458\u2013468. https:\/\/doi.org\/10.1159\/000343875 (2014).","journal-title":"Liver Cancer"},{"key":"78840_CR61","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68, 723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913 (2018).","journal-title":"Hepatology"},{"key":"78840_CR62","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s0002-9610(99)80227-x","volume":"169","author":"S Miyagawa","year":"1995","unstructured":"Miyagawa, S., Makuuchi, M., Kawasaki, S. & Kakazu, T. Criteria for safe hepatic resection. Am. J. Surg. 169, 589\u2013594. https:\/\/doi.org\/10.1016\/s0002-9610(99)80227-x (1995).","journal-title":"Am. J. Surg."},{"key":"78840_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40792-020-00866-1","volume":"6","author":"S Nemoto","year":"2020","unstructured":"Nemoto, S. et al. A patient with post-Fontan operation underwent left hepatectomy and caudate lobectomy for hepatocellular carcinoma: a case report. Surg. Case Rep. 6, 104. https:\/\/doi.org\/10.1186\/s40792-020-00866-1 (2020).","journal-title":"Surg. Case Rep."},{"key":"78840_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijscr.2019.05.029","volume":"59","author":"R Angelico","year":"2019","unstructured":"Angelico, R. et al. Laparoscopic liver resection for hepatocellular carcinoma in Fontan-associated chronic liver disease. The first case report. Int. J. Surg. Case Rep. 59, 144\u2013147. https:\/\/doi.org\/10.1016\/j.ijscr.2019.05.029 (2019).","journal-title":"Int. J. Surg. Case Rep."},{"key":"78840_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12893-020-00741-8","volume":"20","author":"Y Yokota","year":"2020","unstructured":"Yokota, Y. et al. A case report of Fontan procedure-related hepatocellular carcinoma: pure laparoscopic approach by low and stable pneumoperitoneum. BMC Surg. 20, 80. https:\/\/doi.org\/10.1186\/s12893-020-00741-8 (2020).","journal-title":"BMC Surg."},{"key":"78840_CR66","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/hep.30194","volume":"69","author":"C Mazzarelli","year":"2019","unstructured":"Mazzarelli, C. et al. Hepatocellular carcinoma as a complication of vascular disease of the liver after Fontan procedure. Hepatology 69, 911\u2013913. https:\/\/doi.org\/10.1002\/hep.30194 (2019).","journal-title":"Hepatology"},{"key":"78840_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12328-019-01010-9","volume":"13","author":"Y Ogasawara","year":"2020","unstructured":"Ogasawara, Y. et al. A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy. Clin. J. Gastroenterol. 13, 73\u201378. https:\/\/doi.org\/10.1007\/s12328-019-01010-9 (2020).","journal-title":"Clin. J. Gastroenterol."},{"key":"78840_CR68","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","volume":"81","author":"M Mizumoto","year":"2011","unstructured":"Mizumoto, M. et al. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 81, 1039\u20131045. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.015 (2011).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"78840_CR69","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004809","author":"DJ Goldberg","year":"2017","unstructured":"Goldberg, D. J. et al. Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.004809 (2017).","journal-title":"J. Am. Heart Assoc."},{"issue":"938\u2013945","key":"78840_CR70","doi-asserted-by":"publisher","first-page":"945.e931","DOI":"10.1016\/j.cgh.2007.02.039","volume":"5","author":"GN Ioannou","year":"2007","unstructured":"Ioannou, G. N. et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 5(938\u2013945), 945.e931\u2013934. https:\/\/doi.org\/10.1016\/j.cgh.2007.02.039 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"78840_CR71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2014.03.001","volume":"173","author":"H Ohuchi","year":"2014","unstructured":"Ohuchi, H. et al. Comparison of prognostic variables in children and adults with Fontan circulation. Int. J. Cardiol. 173, 277\u2013283. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.001 (2014).","journal-title":"Int. J. Cardiol."},{"key":"78840_CR72","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.jacc.2015.07.065","volume":"66","author":"KN Pundi","year":"2015","unstructured":"Pundi, K. N. et al. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J. Am. Coll. Cardiol. 66, 1700\u20131710. https:\/\/doi.org\/10.1016\/j.jacc.2015.07.065 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"78840_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13582","author":"E Rodr\u00edguez de Santiago","year":"2020","unstructured":"Rodr\u00edguez de Santiago, E., T\u00e9llez, L., Guerrero, A. & Albillos, A. Hepatocellular carcinoma after Fontan surgery: a systematic review. Hepatol. Res. https:\/\/doi.org\/10.1111\/hepr.13582 (2020).","journal-title":"Hepatol. Res."},{"key":"78840_CR74","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1053\/j.gastro.2011.03.010","volume":"140","author":"J Bruix","year":"2011","unstructured":"Bruix, J. et al. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. Gastroenterology 140, 1990\u20131999. https:\/\/doi.org\/10.1053\/j.gastro.2011.03.010 (2011).","journal-title":"Gastroenterology"},{"key":"78840_CR75","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","volume":"126","author":"A Sangiovanni","year":"2004","unstructured":"Sangiovanni, A. et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126, 1005\u20131014. https:\/\/doi.org\/10.1053\/j.gastro.2003.12.049 (2004).","journal-title":"Gastroenterology"},{"key":"78840_CR76","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00246-012-0315-7","volume":"33","author":"J Rychik","year":"2012","unstructured":"Rychik, J. et al. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr. Cardiol. 33, 1001\u20131012. https:\/\/doi.org\/10.1007\/s00246-012-0315-7 (2012).","journal-title":"Pediatr. Cardiol."},{"key":"78840_CR77","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2241","author":"DR DeMaso","year":"2017","unstructured":"DeMaso, D. R. et al. Psychiatric disorders in adolescents with single ventricle congenital heart disease. Pediatrics https:\/\/doi.org\/10.1542\/peds.2016-2241 (2017).","journal-title":"Pediatrics"},{"key":"78840_CR78","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.jacc.2010.11.068","volume":"57","author":"E Goossens","year":"2011","unstructured":"Goossens, E. et al. Transfer of adolescents with congenital heart disease from pediatric cardiology to adult health care: an analysis of transfer destinations. J. Am. Coll. Cardiol. 57, 2368\u20132374. https:\/\/doi.org\/10.1016\/j.jacc.2010.11.068 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"78840_CR79","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ejrad.2016.02.002","volume":"85","author":"JM Bae","year":"2016","unstructured":"Bae, J. M. et al. Fontan-associated liver disease: spectrum of US findings. Eur. J. Radiol. 85, 850\u2013856. https:\/\/doi.org\/10.1016\/j.ejrad.2016.02.002 (2016).","journal-title":"Eur. J. Radiol."},{"key":"78840_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijcard.2015.12.033","volume":"206","author":"D Josephus-Jitta","year":"2016","unstructured":"Josephus-Jitta, D. et al. Three cases of hepatocellular carcinoma in Fontan patients: review of the literature and suggestions for hepatic screening. Int. J. Cardiol. 206, 21\u201326. https:\/\/doi.org\/10.1016\/j.ijcard.2015.12.033 (2016).","journal-title":"Int. J. Cardiol."},{"key":"78840_CR81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/gut.2005.069153","volume":"55","author":"J Foucher","year":"2006","unstructured":"Foucher, J. et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55, 403\u2013408. https:\/\/doi.org\/10.1136\/gut.2005.069153 (2006).","journal-title":"Gut"},{"key":"78840_CR82","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/hep.26631","volume":"59","author":"SS Kutty","year":"2014","unstructured":"Kutty, S. S. et al. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study. Hepatology 59, 251\u2013260. https:\/\/doi.org\/10.1002\/hep.26631 (2014).","journal-title":"Hepatology"},{"key":"78840_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cld.681","volume":"11","author":"T Diamond","year":"2018","unstructured":"Diamond, T. & Ovchinsky, N. Fontan-associated liver disease: Monitoring progression of liver fibrosis. Clin. Liver Dis. (Hoboken) 11, 1\u20135. https:\/\/doi.org\/10.1002\/cld.681 (2018).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"78840_CR84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1747-0803.2009.00255.x","volume":"4","author":"SH Ewe","year":"2009","unstructured":"Ewe, S. H. & Tan, J. L. Hepatocelluar carcinoma\u2014a rare complication post fontan operation. Congenit. Heart Dis. 4, 103\u2013106 (2009).","journal-title":"Congenit. Heart Dis."},{"key":"78840_CR85","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/MEG.0b013e32832e2bec","volume":"22","author":"T Saliba","year":"2010","unstructured":"Saliba, T. et al. Hepatocellular carcinoma in two patients with cardiac cirrhosis. Eur. J. Gastroenterol. Hepatol. 22, 889\u2013891. https:\/\/doi.org\/10.1097\/MEG.0b013e32832e2bec (2010).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"78840_CR86","doi-asserted-by":"publisher","first-page":"E140","DOI":"10.1111\/j.1440-1754.2010.01932.x","volume":"48","author":"J Rosenbaum","year":"2012","unstructured":"Rosenbaum, J., Vrazas, J., Lane, G. K. & Hardikar, W. Cardiac cirrhosis and hepatocellular carcinoma in a 13-year-old treated with doxorubicin microbead transarterial chemoembolization. J. Paediatr. Child Health 48, E140-143. https:\/\/doi.org\/10.1111\/j.1440-1754.2010.01932.x (2012).","journal-title":"J. Paediatr. Child Health"},{"key":"78840_CR87","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1056\/NEJMc1306854","volume":"369","author":"RW Elder","year":"2013","unstructured":"Elder, R. W., Parekh, S. & Book, W. M. More on hepatocellular carcinoma after the Fontan procedure. N. Engl. J. Med. 369, 490. https:\/\/doi.org\/10.1056\/NEJMc1306854 (2013).","journal-title":"N. Engl. J. Med."},{"key":"78840_CR88","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00247-012-2531-y","volume":"43","author":"DB Wallihan","year":"2013","unstructured":"Wallihan, D. B. & Podberesky, D. J. Hepatic pathology after Fontan palliation: spectrum of imaging findings. Pediatr. Radiol. 43, 330\u2013338. https:\/\/doi.org\/10.1007\/s00247-012-2531-y (2013).","journal-title":"Pediatr. Radiol."},{"key":"78840_CR89","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/qjmed\/hcu020","volume":"107","author":"N Rajoriya","year":"2014","unstructured":"Rajoriya, N., Clift, P., Thorne, S., Hirschfield, G. M. & Ferguson, J. W. A liver mass post-Fontan operation. QJM 107, 571\u2013572. https:\/\/doi.org\/10.1093\/qjmed\/hcu020 (2014).","journal-title":"QJM"},{"key":"78840_CR90","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1213\/XAA.0000000000000012","volume":"2","author":"PD Weyker","year":"2014","unstructured":"Weyker, P. D., Allen-John Webb, C., Emond, J. C., Brentjens, T. E. & Johnston, T. A. Anesthetic implications of extended right hepatectomy in a patient with fontan physiology. A A Case Rep 2, 99\u2013101. https:\/\/doi.org\/10.1213\/XAA.0000000000000012 (2014).","journal-title":"A A Case Rep"},{"key":"78840_CR91","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/ped.12619","volume":"57","author":"K Yamada","year":"2015","unstructured":"Yamada, K. et al. Transarterial embolization for pediatric hepatocellular carcinoma with cardiac cirrhosis. Pediatr. Int. 57, 766\u2013770. https:\/\/doi.org\/10.1111\/ped.12619 (2015).","journal-title":"Pediatr. Int."},{"key":"78840_CR92","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.3978\/j.issn.2078-6891.2015.009","volume":"6","author":"S Kwon","year":"2015","unstructured":"Kwon, S. et al. Surgical management of hepatocellular carcinoma after Fontan procedure. J. Gastrointest. Oncol. 6, E55-60. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.009 (2015).","journal-title":"J. Gastrointest. Oncol."},{"key":"78840_CR93","doi-asserted-by":"publisher","first-page":"e4823","DOI":"10.1097\/MD.0000000000004823","volume":"95","author":"C Oh","year":"2016","unstructured":"Oh, C. et al. Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: a case report. Medicine (Baltimore) 95, e4823. https:\/\/doi.org\/10.1097\/MD.0000000000004823 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"78840_CR94","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.2169\/internalmedicine.55.6869","volume":"55","author":"Y Takuma","year":"2016","unstructured":"Takuma, Y. et al. Surgical resection for hepatocellular carcinoma with cardiac cirrhosis after the Fontan procedure. Intern. Med. 55, 3265\u20133272. https:\/\/doi.org\/10.2169\/internalmedicine.55.6869 (2016).","journal-title":"Intern. Med."},{"key":"78840_CR95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/tgh.2018.07.10","volume":"3","author":"KS Lo","year":"2018","unstructured":"Lo, K. S. et al. Left hepatectomy in a patient with a Fontan circulation. Transl. Gastroenterol. Hepatol. 3, 51. https:\/\/doi.org\/10.21037\/tgh.2018.07.10 (2018).","journal-title":"Transl. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78840-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78840-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78840-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:41:23Z","timestamp":1670373683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78840-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78840-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KT has received research funding from Sumitomo Dainippon Pharma Co., Ltd., Astellas Pharma Inc., Eisai Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Pharmaceutical Co., Ltd., AbbVie GK, Takeda Pharmaceutical Co. Ltd., Asahi Kasei Corporation. Ajinomoto Co., Inc., and Otsuka Pharmaceutical Co., Ltd. TK; Nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21742"}}